相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
Timothy Cloughesy et al.
NEURO-ONCOLOGY (2019)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
ATIM-19. RESULTS OF THE GLOBE STUDY: A PHASE 3, RANDOMIZED, CONTROLLED, DOUBLE-ARM, OPEN-LABEL, MULTI-CENTER STUDY OF VB-111 COMBINED WITH BEVACIZUMAB VS. BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Timothy Cloughesy et al.
NEURO-ONCOLOGY (2018)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Paul M. Foreman et al.
NEUROTHERAPEUTICS (2017)
Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma
Nan Ji et al.
ONCOTARGET (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Lee A. Wheeler et al.
NEURO-ONCOLOGY (2016)
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F. Cloughesy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
Daxa M. Patel et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2016)
Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial.
Andrew Jacob Brenner et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cytomegalovirus and glioblastoma; controversies and opportunities
Sean E. Lawler
JOURNAL OF NEURO-ONCOLOGY (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schoenfeld et al.
MOLECULAR THERAPY (2015)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Jianfang Ning et al.
FRONTIERS IN MICROBIOLOGY (2014)
Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults
Kimberly P. Kicielinski et al.
MOLECULAR THERAPY (2014)
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Manfred Westphal et al.
LANCET ONCOLOGY (2013)
Suicide gene therapy in cancer: Where do we stand now?
Sonia Duarte et al.
CANCER LETTERS (2012)
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy
Yurai Okaji et al.
EUROPEAN JOURNAL OF CANCER (2008)
Oncolytic virus therapy using genetically engineered herpes simplex viruses
Tomoki Todo
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
A phase I trial of Ad•hIFN-β gene therapy for glioma
E. Antonio Chiocca et al.
MOLECULAR THERAPY (2008)
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas
Peter Forsyth et al.
MOLECULAR THERAPY (2008)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase
K. Cornetta et al.
CANCER GENE THERAPY (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme:: biological and clinical results
F Colombo et al.
CANCER GENE THERAPY (2005)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo et al.
CANCER RESEARCH (2005)
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor
H Kambara et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MTH-68/H oncolytic viral treatment in human high-grade gliomas
LK Csatary et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma:: A randomised, controlled study
A Immonen et al.
MOLECULAR THERAPY (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas
IM Germano et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma
J Voges et al.
ANNALS OF NEUROLOGY (2003)
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma:: Biological and clinical results
FF Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir
PS Smitt et al.
MOLECULAR THERAPY (2003)
Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial
MD Prados et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses
AM Sandmair et al.
HUMAN GENE THERAPY (2000)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors
TW Trask et al.
MOLECULAR THERAPY (2000)
Multicolumn infusion of gene therapy cells into human brain tumors: Technical report
NH Qureshi et al.
NEUROSURGERY (2000)
分享论文
